Evidence map›Paper›PMID 41140528›Full record

ArticleCurrent research in microbial sciences2025

Antifungal activity of ETD151 against azole-susceptible and -resistant

Camille Rochard, Jeanne Bigot, Nicolas Millet, Viviane Balloy, Isabel Valsecchi, Françoise Botterel, Romain Morichon, Thierry Fontaine, Loïc Guillot, Philippe Bulet and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in microbial sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Camille RochardSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Jeanne BigotSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Nicolas MilletSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Viviane BalloySorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Isabel ValsecchiUniversité Paris-Est Créteil, Ecole nationale vétérinaire d'Alfort, USC ANSES, Dynamyc research team, Créteil, F-94000, France.
Françoise BotterelUniversité Paris-Est Créteil, Ecole nationale vétérinaire d'Alfort, USC ANSES, Dynamyc research team, Créteil, F-94000, France.
Romain MorichonSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Thierry FontaineInstitut Pasteur, Université Paris Cité, INRAE, USC2019, Unité Biologie et Pathogénicité Fongiques, F-75015 Paris, France.
Loïc GuillotSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Philippe BuletInstitut pour l'Avancée des Biosciences (IAB), INSERM 1209, CNRS UMR 5309, Team RNA, Epigenetics and Stress, Université Grenoble Alpes, Grenoble, France.
Christophe HennequinSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
Juliette GuitardSorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillus fumigatus is an opportunistic pathogen responsible for a wide spectrum of severe diseases, depending on the host's immune status. Current therapeutic options against this fungus are limited, and the emergence of resistance against azole derivatives, which are the first-line therapy, regardless of the clinical form, poses serious clinical challenges. Antimicrobial peptides, now used routinely, are valuable alternatives to conventional antibiotics for treating certain bacterial infections. In this study, we investigated the antifungal potential of ETD151, a synthetic peptide, against

Indexed as

AntifungalsAntimicrobial peptidesAntimicrobial resistanceAspergillus fumigatusAzole resistant strain

Identifiers

PMID41140528
PMCPMC12552151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.